What concerns me is the casual indifference on the part of doctors whose judgment patients must come to trust. It's a credibility
and trust issue and doctors must always pass those types of tests. But what do we get? Quotes like the one Ben McGraw, an
ex-Wall Street analyst at the California-based biotech firm Valentis, told The Seattle Times "Everybody does this.... It's now common practice."
Okay, so the practice of doctors talking to analysts is more pervasive these days. But that doesn't make it right. Any time
money changes hands between doctors and slick Wall Street market mavens, any investor's antennae ought to go up (not to mention
the patients who may one day use the drug in question).
Now it's time for this practice to fail its clinical trial.
Celebrity author and business/finance commentator for CNN and Fox News, Brian O'Connell has written for The Wall Street Journal and Newsweek,79 Radcliffe Drive,Doylestown,PA 18901,267.880.3144, fax 267.880.1939, firstname.lastname@example.org